Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy

about

Multidisciplinary treatment of rectal cancer in 2014: where are we going?

P2860

Q34093825-4B3648F6-A733-4561-9CAE-8005C26054B9

P2860

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy

Item

http://www.wikidata.org/entity/Q37106318

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Future directions in combined ...... cision after chemoradiotherapy

@en

Future directions in combined ...... ision after chemoradiotherapy.

@nl

type

Item

label

Future directions in combined ...... cision after chemoradiotherapy

@en

Future directions in combined ...... ision after chemoradiotherapy.

@nl

prefLabel

Future directions in combined ...... cision after chemoradiotherapy

@en

Future directions in combined ...... ision after chemoradiotherapy.

@nl

P1476

Future directions in combined ...... cision after chemoradiotherapy

@en

P2093

Abhishek A Solanki

http://www.w3.org/2001/XMLSchema#string

Daniel T Chang

http://www.w3.org/2001/XMLSchema#string

Stanley L Liauw

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of life after rectal resection for cancer, with or without permanent colostomy

Laparoscopic versus open total mesorectal excision for rectal cancer

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy.

Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

Total mesorectal excision: assessment of the laparoscopic approach.

A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Hydroxymethylglutaryl-coenzyme a synthase 2 expression is associated with chemoradiotherapy responses in colorectal cancer.

P304

1097-1110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S34869

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256190120

http://www.w3.org/2001/XMLSchema#string

P698

23983475

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3747849

http://www.w3.org/2001/XMLSchema#string

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy

about

P2860

P2860

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P921

P932